Results 121 to 130 of about 59,185 (303)

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Journal of Infectious Diseases, 2018
Background The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01B Adjuvant System, was highly efficacious in preventing herpes zoster in the ZOE-50 and ZOE-70 trials.
A. Cunningham, T. Heineman, Himal Lal, O. Godeaux, R. Chlibek, Shinn-Jang Hwang, J. Mcelhaney, T. Vesikari, C. Andrews, W. Choi, Meral Esen, H. Ikematsu, Martina Kovac Choma, K. Pauksens, S. Ravault, B. Salaun, T. Schwarz, J. Smetana, C. V. Abeele, P. Van den Steen, Ilse Vastiau, L. Weckx, M. Levin   +22 more
semanticscholar   +1 more source

Associations between herpes zoster vaccination and herpes zoster with dementia risk in APOE‐e4 carriers and non‐carriers

Alzheimer's &Dementia, Volume 21, Issue S6, December 2025.
Abstract Background Recent studies have reported a reduced risk of dementia in herpes zoster vaccine (HZ‐Vx) recipients. However, none evaluated whether genetic factors influence this potentially protective effect. We used the UK Biobank (UKB) and FinnGen (FG) cohorts to investigate associations between HZ‐Vx or herpes zoster (HZ; shingles) and ...
Jonathan Davitte, Usha Gungabissoon, Jessica Chao, Spiros Denaxas, Ian J Douglas, Ana Torralbo, Cai Ytsma, Chris Tomlinson, Natalie K Fitzpatrick, Jorge Esparza Gordillo, Andrew M Goldfine, Paul J Harrison, Maxime Taquet, Robert A Scott, John A Todd, Chun‐Fang Xu   +15 more
wiley   +1 more source

Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study

BMJ Open, 2020
Objectives To assess the impact of herpes zoster vaccination in the 5 years after introduction for 70- to 79-year-olds in England in September 2013.Design Population based ecological impact assessment.Setting Hospitals covering the whole English ...
Nick Andrews, Simon de Lusignan, Mary Ramsay, Ivelina Yonova, Gayatri Amirthalingam, Julia Stowe, Galena Kuyumdzhieva, Bersabeh Sile   +7 more
doaj   +1 more source

Recombinant zoster vaccine is associated with lower risk of dementia in adults aged ≥65 years

Alzheimer's &Dementia, Volume 21, Issue S7, December 2025.
Abstract Background Vaccines to prevent herpes zoster, historically zoster vaccine live (ZVL), have been associated with reduced dementia risk. We evaluated the association between recombinant zoster vaccine (RZV) and reduction in all‐cause dementia in adults aged ≥65 years at Kaiser Permanente Southern California.
Emily Rayens, Lina Sy, Lei Qian, Bradley Ackerson, Julia Tubert, Yi Luo, Punam Modha, Raul Calderon, Elizabeth Chmielewski‐Yee, Driss Oraichi, Huifeng Yun, Carol Koro, Hung Fu Tseng   +12 more
wiley   +1 more source

Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies

Pathogens
Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV).
Delwyn Zhi Jie Lim, Hong Liang Tey, Brenda Mae Alferez Salada, Jolene Ee Ling Oon, Ee-Jin Darren Seah, Nisha Suyien Chandran, Jiun Yit Pan   +6 more
doaj   +1 more source

A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene [PDF]

, 2018
Varicella-zoster virus (VZV), an alphaherpesvirus, establishes lifelong latent infection in the neurons of >90% humans worldwide, reactivating in one-third to cause shingles, debilitating pain and stroke. How VZV maintains latency remains unclear.
Braspenning, S.E. (Shirley E.), Breuer, J. (Judith), Cohrs, R.J. (Randall ), Depledge, D.P. (Daniel P.), Mori, Y. (Yasuko), Ouwendijk, W.J.D. (Werner), Sadaoka, T. (Tomohiko), Verjans, G.M.G.M. (George)   +7 more
core   +6 more sources

Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration [PDF]

, 2017
Varicella zoster virus (VZV) is a highly prevalent human pathogen that establishes latency in neurons of the peripheral nervous system. Primary infection causes varicella whereas reactivation results in zoster, which is often followed by chronic pain in ...
Bauerfeind, R. (Rudolf), Binz, A. (Anne), Durán, V. (Verónica), González-Motos, V. (Víctor), Jonjic, S. (Stipan), Jürgens, C. (Carina), Kalinke, U. (Ulrich), Kaufer, B.B. (Benedikt B.), Krey, T. (Thomas), Kropp, K.A. (Kai A.), Larsen, O. (Olav), Lenac Rovis, T. (Tihana), Ouwendijk, W.J.D. (Werner), Proudfoot, A.E.I. (Amanda E. I.), Ritter, B. (Birgit), Rosenkilde, M.M. (Mette M.), Schulz, T.F. (Thomas F.), Sodeik, B. (Beate), Verjans, G.M.G.M. (George), Viejo-Borbolla, A. (Abel)   +19 more
core   +1 more source

Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques

bioRxiv
Herpes zoster remains an important global health issue and mainly occurs in aged and immunocompromised individuals with an early exposure history to Varicella Zoster Virus (VZV).
Lulu Huang, Tongyi Zhao, Weijun Zhao, Andong Shao, Huajun Zhao, Wenxuan Ma, Yingfei Gong, Xianhuang Zeng, Changzhen Weng, Lingling Bu, Zhenhua Di, Shiyu Sun, Qinsheng Dai, Minhui Sun, Limei Wang, Zhenguang Liu, Leilei Shi, Jiesen Hu, Shentong Fang, Cheng Zhang, Jian Zhang, Guan Wang, K. Loré, Yong Yang, Ang Lin   +24 more
semanticscholar   +1 more source

Kansanterveyslaitoksen asettaman lasten vesirokkorokotustyöryhmän selvitys [PDF]

, 2008
Kansanterveyslaitos asetti 21.1.2007 työryhmän, jonka päätehtävänä oli arvioida, tulisiko vesirokkorokote antaa kaikille lapsille osana yleistä rokotusohjelmaa.

core   +1 more source

Prophylactic vaccination with a live-attenuated herpes zoster vaccine in lung transplant candidates [PDF]

, 2020
Lei Wang, Erik A.M. Verschuuren, Davy Paap, Christien Rondaan, Elisabeth Raveling‐Eelsing, Johanna Westra, Nicolaas A. Bos   +6 more
openalex   +1 more source